In our MB models, increased RHO activity is associated with a more differentiated phenotype, and this is consistent with previous findings in glioblastoma stem cells in which ROCK inhibitor treatment enhanced tumorsphere formation (Tilson et al., 2015). This evidence concerns the gene RHO and glioblastoma.